Latest News and Press Releases

To NASDAQ OMX Copenhagen A/S Announcement no. 26-13 / Copenhagen, November 20, 2013 Topotarget announces the final results from the first stage of the phase II part of the phase I/II clinical...

To NASDAQ OMX Copenhagen A/S Announcement no. 25-13 / Copenhagen, November 7, 2013 Topotarget announces that the board of directors has reviewed and approved the company’s interim report for the...

Til NASDAQ OMX Copenhagen A/S Meddelelse nr. 25-13 / København, 7. november 2013 Topotarget meddeler, at bestyrelsen i dag har behandlet og godkendt selskabets delårsrapport for perioden 1....

Til NASDAQ OMX Copenhagen A/S Meddelelse nr. 24-13 / København, 1. november 2013  Topotarget offentliggør hermed selskabets finanskalender for...

To NASDAQ OMX Copenhagen A/S Announcement no. 24-13 / Copenhagen, November 1, 2013  Topotarget announces its financial calendar for 2014 as...

To NASDAQ OMX Copenhagen A/S Investor News No. 09-13 / Copenhagen, November 1, 2013 Topotarget A/S Topotarget announces that a teleconference will be held on November 7, 2013 at 1:00 pm...

Til NASDAQ OMX Copenhagen A/S Investor Nyhed nr. 09-13 / København, 1. november 2013 Topotarget A/S Topotarget meddelte i dag, at der vil blive afholdt en telekonference den 7. november 2013...

Til NASDAQ OMX Copenhagen A/S Meddelelse nr. 23-13 / København, 7. oktober 2013 Topotarget og Spectrum Pharmaceuticals offentliggør en ændring til selskabernes eksisterende licensaftale. I...

To NASDAQ OMX Copenhagen A/S Announcement no. 23-13 / Copenhagen, October 7, 2013 Topotarget and Spectrum Pharmaceuticals announce an amendment to the companies’ existing License Agreement....

To NASDAQ OMX Copenhagen A/S Investor News No. 08-13 / Copenhagen, August 30, 2013 Topotarget will be presenting at the 15th Annual Rodman & Renshaw Global Investment Conference which is...